Heska Corporation (HSKA): Price and Financial Metrics

Heska Corporation (HSKA): $252.23

2.53 (+1.01%)

POWR Rating

Component Grades














  • HSKA scores best on the Sentiment dimension, with a Sentiment rank ahead of 91.69% of US stocks.
  • The strongest trend for HSKA is in Growth, which has been heading up over the past 31 weeks.
  • HSKA ranks lowest in Stability; there it ranks in the 34th percentile.

HSKA Stock Summary

  • With a one year PEG ratio of 1,253.55, Heska Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 96.32% of US stocks.
  • The price/operating cash flow metric for Heska Corp is higher than 99.14% of stocks in our set with a positive cash flow.
  • Revenue growth over the past 12 months for Heska Corp comes in at 83.49%, a number that bests 92.88% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Heska Corp are CDNA, TNDM, OSUR, APPN, and CEVA.
  • HSKA's SEC filings can be seen here. And to visit Heska Corp's official web site, go to www.heska.com.

HSKA Valuation Summary

  • HSKA's price/earnings ratio is -363.1; this is 1167.94% lower than that of the median Healthcare stock.
  • HSKA's price/sales ratio has moved up 10.7 over the prior 243 months.
  • HSKA's price/sales ratio has moved up 10.7 over the prior 243 months.

Below are key valuation metrics over time for HSKA.

Stock Date P/S P/B P/E EV/EBIT
HSKA 2020-03-05 6.1 4.8 -510.2 -711100.0
HSKA 2012-04-12 0.8 1.2 27.6 16.3
HSKA 2011-09-07 0.7 1.0 25.0 14.3
HSKA 2008-12-18 0.2 0.3 0.4 6.8
HSKA 2007-11-12 1.3 9.8 20.1 16.7
HSKA 2002-06-24 0.6 2.3 -1.7 -2.0

HSKA Growth Metrics

  • Its 2 year price growth rate is now at -11.82%.
  • The year over year price growth rate now stands at 149.05%.
  • Its year over year revenue growth rate is now at 83.49%.
Over the past 15 months, HSKA's revenue has gone up $104,512,000.

The table below shows HSKA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 227.173 5.442 -7.24
2020-12-31 197.323 -0.656 -14.399
2020-09-30 166.769 -1.529 -18.592
2020-06-30 141.37 -4.443 -13.683
2020-03-31 123.804 -2.192 -7.567
2019-12-31 122.661 3.296 -1.465

HSKA Price Target

For more insight on analysts targets of HSKA, see our HSKA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $221.75 Average Broker Recommendation 1.75 (Moderate Buy)

HSKA Stock Price Chart Interactive Chart >

Price chart for HSKA

HSKA Price/Volume Stats

Current price $252.23 52-week high $255.75
Prev. close $249.70 52-week low $87.62
Day low $249.22 Volume 22,500
Day high $253.00 Avg. volume 75,793
50-day MA $223.28 Dividend yield N/A
200-day MA $175.82 Market Cap 2.63B

Heska Corporation (HSKA) Company Bio

Heska Corporation sells advanced veterinary diagnostic and other specialty veterinary products, including blood testing instruments and supplies, digital imaging products, software and services, and single-use products and services such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing. The company was founded in 1988 and is based in Loveland, Colorado.

HSKA Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$252.23$16.81 -92%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Heska Corp. To summarize, we found that Heska Corp ranked in the 11th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 92%. In terms of the factors that were most noteworthy in this DCF analysis for HSKA, they are:

  • Heska Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.8. This coverage rate is greater than that of only 18.76% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • Relative to other stocks in its sector (Healthcare), Heska Corp has a reliance on debt greater than just 22.95% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Heska Corp? See COO, RGEN, HALO, OPK, and RHE.

HSKA Latest News Stream

Event/Time News Detail
Loading, please wait...

HSKA Latest Social Stream

Loading social stream, please wait...

View Full HSKA Social Stream

Latest HSKA News From Around the Web

Below are the latest news stories about Heska Corp that investors may wish to consider to help them evaluate HSKA as an investment opportunity.

What Does Heska Corporation's (NASDAQ:HSKA) Share Price Indicate?

Heska Corporation ( NASDAQ:HSKA ), is not the largest company out there, but it saw a significant share price rise of...

Yahoo | July 26, 2021

10 Best Stocks for Animal Lovers

In this article we will list the 10 best stocks for animal lovers. If you want to skip our detailed analysis of the pet industry, go directly to the 5 Best Stocks for Animal Lovers. Pets are increasingly considered as part of our families and you can see this in pet industry numbers too. According […]

Yahoo | July 14, 2021

Hedge Funds Are Crazy About Heska Corp (HSKA)

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]

Yahoo | July 13, 2021

Heska Second Quarter 2021 Financial Results and Earnings Call Scheduled for August 3, 2021

Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, will report its second quarter 2021 financial performance in a press release before the market opens on Tuesday, August 3, 2021. The Company will also host an earnings call at 9 a.m. MT / 11 a.m. ET to discuss the results.

Yahoo | July 13, 2021

Heska, CEO Kevin Wilson sign new employment agreement

LOVELAND Heska Corp. (Nasdaq: HSKA) has signed a new employment agreement with CEO Kevin Wilson, extending his tenure at least for another four years. The veterinary pharmaceutical and diagnostic company on June 8 signed an amended and restated employment agreement with Wilson, according to documents filed with the U.S. Securities and Exchange Commission. The []

Greeley Tribune | June 12, 2021

Read More 'HSKA' Stories Here

HSKA Price Returns

1-mo 9.79%
3-mo 38.09%
6-mo 50.71%
1-year 159.12%
3-year 151.60%
5-year 492.78%
YTD 73.18%
2020 51.81%
2019 11.43%
2018 7.34%
2017 12.03%
2016 85.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8326 seconds.